四川港通医疗设备集团股份有限公司的主营业务是医用气体装备及系统、医用洁净装备及系统的研发、 设计、制造、集成及运维服务。公司的主要产品是医用气体装备及系统、医用洁净装备及系统、医疗设 备及其他产品销售、运维服务。公司先后被评为"国家级专精特新小巨人企业""国家级高新技术企 业""四川省行业小巨人企业""中国气体行业领军企业""全国医用气体优秀工程企业""中国医用气体装备 创新基地""全国医用气体从业人员培训基地"。 最新一期业绩显示，2025年一季报，公司实现营业收入2428.67万元，同比-68.09%；净利润157.90万 元，同比-85.25%，销售毛利率36.15%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)120港通医疗366.87134.661.5619.42亿行业平均 49.2647.464.56105.99亿行业中值36.7137.322.4947.70亿1天益医疗-1763.34-3020.401.8822.47亿2澳华内 镜-613.48307.694.9164.65亿3诺唯赞-411.11-486.242.2687.98亿4爱朋医疗-367.45279.154.4330.1 ...

江苏宝利国际投资股份有限公司的主营业务是通用型改性沥青、高强度结构沥青料、高铁专用乳化沥 青、废橡塑改性沥青等专业沥青产品的生产销售；直升机及航材的销售业务；BT项目投资业务。公司 的主要产品是道路石油沥青、通用改性沥青、飞行器租售及运营。 最新一期业绩显示，2025年一季报，公司实现营业收入2.30亿元，同比-42.82%；净利润323.90万元，同 比-26.61%，销售毛利率1.83%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)154宝利国际170.55161.573.7236.03亿行业平均 43.8351.703.9978.70亿行业中值39.3439.752.3041.51亿1渝三峡A-3559.771297.744.5556.67亿2锦鸡股 份-404.94603.002.0134.08亿3安诺其-332.58-1357.232.5464.41亿4信德新材-257.22-108.321.3335.79亿5石 大胜华-178.65433.141.8371.12亿6鼎际得-174.30-283.162.1834.35亿7富淼科技-151.24-421.471.4619.62亿8 达威股 ...

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Furuya Co., which operates in the medical device industry, specifically focusing on liver disease-related products and services [1][2] - As of May 19, Furuya Co. closed at 30.48 yuan, with a decline of 1.20%, resulting in a rolling price-to-earnings (PE) ratio of 81.84 times, significantly higher than the industry average of 49.26 times and the median of 36.71 times [1][2] - The total market capitalization of Furuya Co. is reported at 8.119 billion yuan, ranking it 102nd in the industry based on PE ratio [1][2] Group 2 - For the first quarter of 2025, Furuya Co. reported a revenue of 330 million yuan, reflecting a year-on-year increase of 2.35%, while the net profit was 28.637 million yuan, showing a decline of 32.97% compared to the previous year [1] - The gross profit margin for Furuya Co. stands at 76.76%, indicating a strong profitability despite the drop in net profit [1] - As of the first quarter of 2025, 18 institutions hold shares in Furuya Co., including 14 funds, 3 other entities, and 1 insurance company, with a total holding of 49.9011 million shares valued at 1.593 billion yuan [1]

智通财经5月16日电，宁波远洋(601022.SH)发布异动公告，根据中证指数网发布的数据，交通运输业、 仓储和邮政业中水上运输业2025年5月15日平均滚动市盈率为9.61倍，行业平均市净率为1.12倍，公司最 新滚动市盈率为25.89倍，最新市净率为2.44倍，明显高于同行业平均水平。敬请广大投资者注意二级市 场交易风险，理性决策，审慎投资。 宁波远洋：最新市净率明显高于同行业平均水平 ...

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Yuexiu Capital, which has a current stock price of 6.51 yuan and a rolling PE ratio of 13.15 times, significantly lower than the industry average of 70.57 times [1][2] - Yuexiu Capital's total market capitalization stands at 32.662 billion yuan, ranking 7th in the diversified financial industry based on PE ratio [1][2] - As of the first quarter of 2025, 10 institutions hold shares in Yuexiu Capital, with a total holding of 397,502.52 thousand shares valued at 25.321 billion yuan [1] Group 2 - The main business of Yuexiu Capital includes non-performing asset management, financing leasing, private equity fund management, and capital investment services, with key products in non-performing asset management and new energy [1] - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 2.742 billion yuan, a year-on-year decrease of 9.42%, while net profit reached 657 million yuan, reflecting a year-on-year increase of 40.52% with a gross profit margin of 22.24% [1]

5月15日，戴维医疗今日收盘12.4元，下跌2.52%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到85.59倍，总市值35.71亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入1.21亿元，同比-22.00%；净利润2256.77万元， 同比-40.78%，销售毛利率57.13%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)102戴维医疗85.5962.363.0035.71亿行业平均 49.4645.354.63105.58亿行业中值36.1637.372.5047.48亿1天益医疗-1720.32-2946.711.8421.92亿2澳华内 镜-597.76299.814.7963.00亿3诺唯赞-409.62-484.482.2587.66亿4爱朋医疗-360.69274.024.3429.60亿5博晖 创新-322.93512.443.4547.38亿6硕世生物-134.71-1968.471.2139.40亿7奥精医疗-119.67-175.401.5822.21亿 8睿昂基因-100.21-82.271.4212.97亿9康泰医学-86.02-72.673 ...

Group 1 - The core business of the company is the research, production, and sales of mid-to-high-end CNC machine tools, including large machining centers, vertical CNC machines, and horizontal CNC machines [2] - As of March 31, 2025, the company had 11,793 shareholders, a decrease of 431 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The company's latest quarterly report for Q1 2025 shows a revenue of 569 million yuan, a year-on-year increase of 3.80%, and a net profit of 61.36 million yuan, a year-on-year decrease of 11.78%, with a gross profit margin of 21.11% [2] Group 2 - The company's current rolling price-to-earnings (PE) ratio is 19.52, while the average PE ratio for the general equipment industry is 79.52, and the industry median is 41.26, placing the company at the 68th position in the industry ranking [1][3] - The company has received multiple honors, including recognition as a Jiangsu Province Intelligent Manufacturing Factory and a Jiangsu Province Five-Star Cloud Enterprise, among others [2]

健帆生物科技集团股份有限公司的主营业务是生物材料和高科技医疗器械的研发、生产及销售。公司的 主要产品是HA系列血液灌流器、KHA系列血液灌流器、pHA系列血液灌流器、HA330-Ⅱ血液灌流器、 透析粉液、消毒液、一次性使用血液透析器、DX-10血液净化机、血液灌流机、FutureF20血液净化设 备、FutureF20血液净化设备。公司先后获评为国家火炬计划重点高新技术企业、国家制造业单项冠军 示范企业、国家技术创新示范企业、国家知识产权示范企业。荣获国家科技进步二等奖、广东省科学技 术进步一等奖，获批组建国家企业技术中心、院士工作站、博士后工作站等科研平台，并承担30多项国 家、省、市级科技及产业化项目，具备从原材料制备到产品制造的完全自主知识产权。 最新一期业绩显示，2025年一季报，公司实现营业收入5.48亿元，同比-26.40%；净利润1.89亿元，同 比-33.71%，销售毛利率80.74%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)53健帆生物23.8421.055.06172.66亿行业平均 49.4645.354.63105.58亿行业中值36.1637.372.5047.48亿 ...

序号股票简称PE(TTM)PE(静)市净率总市值(元)16通源石油44.6642.091.6823.42亿行业平均 26.2430.042.85136.45亿行业中值36.9136.872.7147.51亿1贝肯能源-3245.11418.552.6518.09亿2潜能恒 信-143.68-97.254.7451.36亿3准油股份-73.50-95.4329.0215.02亿4新锦动力-43.20-16.24-11.6526.92亿5惠博 普-19.35-18.021.4734.41亿6海默科技-15.91-15.732.7835.92亿7中曼石油10.1510.941.8779.43亿8海油工程 10.3810.700.86231.24亿9海油发展10.7411.011.45402.54亿10金诚信13.2514.492.46229.42亿11中海油服 18.9420.461.44641.78亿 来源：金融界 最新一期业绩显示，2025年一季报，公司实现营业收入2.58亿元，同比13.21%；净利润78.27万元，同 比-80.38%，销售毛利率22.53%。 5月15日，通源石油今日收盘3.98元，下跌1 ...

最新一期业绩显示，2025年一季报，公司实现营业收入17.36亿元，同比-9.67%；净利润3.79亿元，同 比-21.44%，销售毛利率64.03%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)110乐普医疗147.5985.831.38211.94亿行业平均 49.4645.354.63105.58亿行业中值36.1637.372.5047.48亿1天益医疗-1720.32-2946.711.8421.92亿2澳华内 镜-597.76299.814.7963.00亿3诺唯赞-409.62-484.482.2587.66亿4爱朋医疗-360.69274.024.3429.60亿5博晖 创新-322.93512.443.4547.38亿6硕世生物-134.71-1968.471.2139.40亿7奥精医疗-119.67-175.401.5822.21亿 8睿昂基因-100.21-82.271.4212.97亿9康泰医学-86.02-72.673.0756.61亿10中红医疗-69.48-55.420.8848.28亿 11华大智造-62.11-55.114.28331.13亿 来源：金融界 从行业 ...